Erratum to: Repeat Rifaximin for Irritable Bowel Syndrome: No Clinically Significant Changes in Stool Microbial Antibiotic Sensitivity

Excerpt

The article Repeat Rifaximin for Irritable Bowel Syndrome: No Clinically Significant Changes in Stool Microbial Antibiotic Sensitivity, written by M. Pimentel, B. D. Cash, A. Lembo, R. A. Wolf, R. J. Israel, and P. Schoenfeld, was originally published Online First without open access. After publication in volume 62, issue 9, page 2455–2463, the author decided to opt for Open Choice and to make the article an open-access publication. Therefore, the copyright of the article has been changed to © The Author(s) 2017, and the article is forthwith distributed under the terms of the Creative Commons Attribution Attribution-NonCommercial 4.0 International License (http://​creativecommons.​org/​licenses/​by-nc/​4.​0/​), which permits any noncommercial use, duplication, adaptation, distribution, and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, a link is provided to the Creative Commons license, and any changes made are indicated. …